Skip to main content
. 2021 Jan 20;93(4):2471–2479. doi: 10.1021/acs.analchem.0c04497

Figure 2.

Figure 2

End to end process for putative biomarkers determination and diagnosis test generation. (a) MS data acquisition and preparation; (b) Sequential steps of ML data analysis and metabolomics biomarkers validation.